SE9700061L - Komposition för reglerad frisättning - Google Patents

Komposition för reglerad frisättning

Info

Publication number
SE9700061L
SE9700061L SE9700061A SE9700061A SE9700061L SE 9700061 L SE9700061 L SE 9700061L SE 9700061 A SE9700061 A SE 9700061A SE 9700061 A SE9700061 A SE 9700061A SE 9700061 L SE9700061 L SE 9700061L
Authority
SE
Sweden
Prior art keywords
controlled release
composition
release composition
active material
biologically active
Prior art date
Application number
SE9700061A
Other languages
English (en)
Other versions
SE511313C2 (sv
SE9700061D0 (sv
Inventor
Kaare Larsson
Helena Ljusberg-Wahren
Niels Krog
Original Assignee
Gs Dev Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gs Dev Ab filed Critical Gs Dev Ab
Priority to SE9700061A priority Critical patent/SE511313C2/sv
Publication of SE9700061D0 publication Critical patent/SE9700061D0/sv
Priority to EP98900793A priority patent/EP0954287B1/en
Priority to JP53080298A priority patent/JP2001508773A/ja
Priority to AT98900793T priority patent/ATE243024T1/de
Priority to AU55832/98A priority patent/AU5583298A/en
Priority to PCT/SE1998/000009 priority patent/WO1998030206A1/en
Priority to CA002277377A priority patent/CA2277377C/en
Priority to DE69815659T priority patent/DE69815659T2/de
Priority to US09/341,294 priority patent/US6660278B1/en
Publication of SE9700061L publication Critical patent/SE9700061L/sv
Publication of SE511313C2 publication Critical patent/SE511313C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE9700061A 1997-01-13 1997-01-13 Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol SE511313C2 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE9700061A SE511313C2 (sv) 1997-01-13 1997-01-13 Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol
US09/341,294 US6660278B1 (en) 1997-01-13 1998-01-08 Controlled release composition
AU55832/98A AU5583298A (en) 1997-01-13 1998-01-08 Controlled release composition
JP53080298A JP2001508773A (ja) 1997-01-13 1998-01-08 徐放性組成物
AT98900793T ATE243024T1 (de) 1997-01-13 1998-01-08 Zusammensetzung zur kontrollierten freisetzung
EP98900793A EP0954287B1 (en) 1997-01-13 1998-01-08 Controlled release composition
PCT/SE1998/000009 WO1998030206A1 (en) 1997-01-13 1998-01-08 Controlled release composition
CA002277377A CA2277377C (en) 1997-01-13 1998-01-08 Controlled release composition
DE69815659T DE69815659T2 (de) 1997-01-13 1998-01-08 Zusammensetzung zur kontrollierten freisetzung

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9700061A SE511313C2 (sv) 1997-01-13 1997-01-13 Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol

Publications (3)

Publication Number Publication Date
SE9700061D0 SE9700061D0 (sv) 1997-01-13
SE9700061L true SE9700061L (sv) 1998-07-14
SE511313C2 SE511313C2 (sv) 1999-09-06

Family

ID=20405393

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9700061A SE511313C2 (sv) 1997-01-13 1997-01-13 Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol

Country Status (9)

Country Link
US (1) US6660278B1 (sv)
EP (1) EP0954287B1 (sv)
JP (1) JP2001508773A (sv)
AT (1) ATE243024T1 (sv)
AU (1) AU5583298A (sv)
CA (1) CA2277377C (sv)
DE (1) DE69815659T2 (sv)
SE (1) SE511313C2 (sv)
WO (1) WO1998030206A1 (sv)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020153508A1 (en) 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
US6946137B2 (en) * 2001-10-19 2005-09-20 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
EP1446103B1 (en) 2001-10-19 2015-12-23 Idexx Laboratories, Inc. Injectable compositions for the controlled delivery of pharmacologically active compound
US7439268B2 (en) * 2003-07-18 2008-10-21 Idexx Laboratories Compositions containing prodrugs of florfenicol and methods of use
US20050049210A1 (en) * 2003-08-27 2005-03-03 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
NZ551990A (en) 2004-06-04 2011-01-28 Camurus Ab Liquid depot formulations
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US20060067977A1 (en) 2004-09-28 2006-03-30 Atrium Medical Corporation Pre-dried drug delivery coating for use with a stent
US9801913B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Barrier layer
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US8124127B2 (en) 2005-10-15 2012-02-28 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
US8535709B2 (en) * 2004-12-13 2013-09-17 Southeastern Medical Technologies, Llc Agents for controlling biological fluids and methods of use thereof
US20060127437A1 (en) * 2004-12-13 2006-06-15 Misty Anderson Kennedy Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
US8288348B2 (en) * 2005-07-13 2012-10-16 Allergan, Inc. Cyclosporin compositions
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
EP2083875B1 (en) 2006-11-06 2013-03-27 Atrium Medical Corporation Coated surgical mesh
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
US7550625B2 (en) * 2007-10-19 2009-06-23 Idexx Laboratories Esters of florfenicol
EP2393472B1 (en) 2008-12-05 2019-06-05 NanoMed Holdings Pty Ltd Amphiphile prodrugs
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
WO2011050388A1 (en) * 2009-10-30 2011-05-05 Monash University Liquid crystal composition and method of use
CN102892414B (zh) * 2010-05-18 2015-05-06 富士胶片株式会社 含类胡萝卜素组合物及其制造方法
WO2012009707A2 (en) 2010-07-16 2012-01-19 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
AU2013294915C1 (en) 2012-07-26 2019-11-21 Camurus Ab Opioid formulations
BR112020010519A2 (pt) 2017-11-27 2020-10-20 Umecrine Cognition Ab formulação farmacêutica de oxima de 3¿lfa-etinil-3¿eta-hidroxiandrostan-17-ona
EP3810622A4 (en) 2018-06-21 2022-04-06 NanoMed Holdings Pty Ltd AMPHIPHILIC PLATINUM-BASED PRODRUGS
CN116867376A (zh) * 2021-01-29 2023-10-10 Ioi油脂化学品有限责任公司 含有聚甘油脂肪酸酯的组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5321393B2 (sv) * 1974-10-19 1978-07-03
US5264460A (en) * 1988-05-30 1993-11-23 Deutsche Solvay-Werke Gmbh Process for preparing nonionic surfactants
KR0148748B1 (ko) 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
IE65045B1 (en) 1990-04-28 1995-10-04 Takeda Chemical Industries Ltd Granulated preparations and method of producing the same
WO1992018147A1 (en) 1991-04-19 1992-10-29 Affinity Biotech, Inc. Convertible microemulsion formulations
SE518578C2 (sv) * 1994-06-15 2002-10-29 Gs Dev Ab Lipidbaserad komposition
US6013269A (en) * 1994-10-12 2000-01-11 The Procter & Gamble Company Cosmetic make-up compositions
SE504582C2 (sv) 1995-07-06 1997-03-10 Gs Dev Ab Cyklosporinkomposition baserad på en L2-fas
CZ288739B6 (cs) * 1996-08-01 2001-08-15 Galena, A. S. Cyklosporin obsahující léčivé přípravky

Also Published As

Publication number Publication date
US6660278B1 (en) 2003-12-09
JP2001508773A (ja) 2001-07-03
EP0954287B1 (en) 2003-06-18
EP0954287A1 (en) 1999-11-10
CA2277377A1 (en) 1998-07-16
WO1998030206A1 (en) 1998-07-16
SE511313C2 (sv) 1999-09-06
CA2277377C (en) 2007-12-18
DE69815659T2 (de) 2004-04-29
ATE243024T1 (de) 2003-07-15
SE9700061D0 (sv) 1997-01-13
AU5583298A (en) 1998-08-03
DE69815659D1 (de) 2003-07-24

Similar Documents

Publication Publication Date Title
SE9700061L (sv) Komposition för reglerad frisättning
TR199701277T1 (xx) Biyoaktif bile�ikler olarak ya� asidi esterleri.
IL106248A (en) Adhesive compositions and method of bonding biological tissue to a substance
EP0152281A3 (en) Transdermal formulation of nicardipine hydrochloride
BR9808668A (pt) Suspensão aquosa de microcápsulas compreendendo um material biologicamente ativo, e, processos para preparação de uma suspensão aquosa de microcápsulas aderentes e para aplicação de microcápsulas em um substrato pretendido
HUP0000937A2 (hu) Új zsírsav-származékok
BR9609033B1 (pt) composição e emulsão para a liberação controlada de uma substáncia.
FI970298A (sv) Användning av DHA som farmaceutisk komposition
ES2173142T3 (es) Dispositivo y procedimiento para la captura y recuperacion de celulas.
MY110984A (en) Immobilized lipases
DE69531864D1 (de) Indolizin spal2 inhibitoren
BR9305636A (pt) Composição compreendendo TCMTB em um portador sólido e métodos para fazer uma composição compreendendo TCMTB e um portador sólido e para impedir o crescimento de um microorganismo.
ES2119825T3 (es) Material de soporte plano, biodegradable, para desnitrificantes en etapas de clarificacion que funcionan biologicamente.
NO933345D0 (no) Forbedrede retardsystemer for tidsforsinket frisetting avmedisinske og/eller biologiske aktive bestanddeler fra etdepot-baerermateriale
YU47192A (sh) Transdermalni tretirajući sistem sa supstancom kao nosačem za potpomaganje transdermalne penetracije i postupak za njegovo dobijanje
GB2324528A (en) Cytostatic hydroxamic acid derivatives
DK0563256T3 (da) Anvendelse af værtscelle-phospholipider til inhibering af bakteriekolonisering
CO4600643A1 (es) Procedimiento de acondicionamiento de tejidos de vegetales cultivados en vitro y dispositivo para dicho acondicionamiento
MY105074A (en) Transdermal therapeutical system comprising norpseudoephedrine as active component.
DE69928524D1 (de) Biologisch aktive zusammensetzung
EP0997735A3 (de) Stabilisierung von biologischen Flüssigkeiten durch Zusatz von Sterinestern
ATE267401T1 (de) Technik zur mikroverkapselung von markierungen
KR970705381A (ko) 흡수성 첨가제를 함유하는 에스트라디올 트랜스더멀 치료 시스템
ID20810A (id) Metoda merawat luka dangkal tidak dijahit dengan menggunakan komposisi ester siano akrilat terdiri dari bahan anti mikroba
AU1895895A (en) Fibrous cellulose-based culture substrate

Legal Events

Date Code Title Description
NUG Patent has lapsed